|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,860.00 KRW | +0.21% |
|
-8.82% | -28.74% |
| 12-09 | GC Genome Study Identifies 'Confounders' Interfering with Cancer Signals to Improve Liquid Biopsy Accuracy | CI |
| 12/06/25 | GC Genome Shares Decline Nearly 3% After Strong Kosdaq Debut | MT |
Business description: GC Genome Corporation

Executive Committee: GC Genome Corporation
| Manager | Title | Age | Since |
|---|---|---|---|
Chang-Seok Gi
CEO | Chief Executive Officer | 57 | 26/03/2020 |
Sang-Hun Jeong
DFI | Director of Finance/CFO | 50 | 27/03/2025 |
Seu-Nga Hyun
AUD | Comptroller/Controller/Auditor | 45 | 29/03/2024 |
Eun-Hae Jo
PRN | Corporate Officer/Principal | 52 | - |
Composition of the Board of Directors: GC Genome Corporation
| Director | Title | Age | Since |
|---|---|---|---|
Sang-Uk Kim
BRD | Director/Board Member | 57 | 30/03/2023 |
Company details: GC Genome Corporation

Medical & Diagnostic Laboratories
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.21% | -8.82% | -52.02% | - | 74.93M | ||
| -2.08% | +3.24% | +31.48% | +322.42% | 33.14B | ||
| -0.21% | -3.68% | -2.20% | +8.68% | 20.98B | ||
| -1.20% | -1.93% | -24.93% | -44.26% | 6.95B | ||
| +2.78% | -3.23% | +0.62% | +68.52% | 4.23B | ||
| +2.20% | +4.39% | +14.81% | +49.81% | 2.9B | ||
| -3.64% | -8.56% | -29.66% | +820.69% | 1.75B | ||
| +0.12% | -2.61% | -8.65% | -66.59% | 1.68B | ||
| +7.62% | -0.81% | +44.44% | -24.96% | 1.65B | ||
| -1.58% | 0.00% | +12.97% | -4.59% | 1.58B | ||
| Average | +0.44% | -1.25% | -1.31% | +125.52% | 7.49B | |
| Weighted average by Cap. | -0.77% | +1.00% | +11.92% | +163.95% |
Sector
Annual profits - Rate of surprise
- Stock Market
- Stocks
- A340450 Stock
- Company GC Genome Corporation
Select your edition
All financial news and data tailored to specific country editions

















